Bactiguard Holding AB (publ) (0QV2.L)

74,00 +12,00 (+19,35%) Alla chiusura: 10:02AM BST

Bactiguard Holding AB (publ)

Vasagatan 11
2nd Floor
Stockholm 111 20
Sweden
46 84 40 58 80
https://www.bactiguard.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 217

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Ms. Christine Lind	Chief Executive Officer	N/D	N/D	1974
Mr. Patrick Fruergaard Bach	Chief Financial Officer	N/D	N/D	1983
Mr. Mikael Sander	Chief Operating Officer	N/D	N/D	1959
Mr. Sathish Subramaniam	Chief Technology Officer	N/D	N/D	1979
Ms. Nina Nornholm	Head of Corporate Communication & Investor Relations	N/D	N/D	1967

Gli importi risalgono al giorno e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in SEK.

Descrizione

Bactiguard Holding AB (publ), a medical device company, provides infection prevention solutions in orthopedics, urology, intravascular/critical care, dental, and wound care therapeutic areas in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally. The company's infection prevention solutions reduce the risk of infections and the use of antibiotics. Its product portfolio consists of Bactiguard infection protection (BIP) Foley Catheter, an indwelling urinary catheter that reduces microbial adhesion; BIP Central Venous Catheter, which reduces the risk of catheter related bloodstream infection and antibiotics; BIP Endotracheal Tube, that reduces the ventilator associated pneumonia, antibiotics, and healthcare costs; BIP Endotracheal Tube Evac, a tube that combines the subglottic secretion drainage with coating to reduce microbial adhesion; and BIP Foley TempSensor, an indwelling urinary catheter that offers surveillance and infection prevention. The company's products also include Hydrocyn aqua, an antimicrobial solution and gel for improved wound healing; and surgical sutures comprising non-absorbable, natural absorbable, synthetic absorable, and specialty sutures. In addition, it offers ZNN Bactiguard, an orthopedic trauma implants with infection prevention technology; and Aniocyn, a wound and skin care products for dogs, cats, horses, and other pets. Bactiguard Holding AB (publ) was founded in 2005 and is headquartered in Stockholm, Sweden.

Governance aziendale

L'ISS Governance QualityScore di Bactiguard Holding AB (publ) al 1 aprile 2024 è 10. I criteri di valutazione fondamentali sono revisione: 8; Consiglio di Amministrazione: 8; diritti degli azionisti: 10; retribuzione: 7.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.